CCO Expert Recap

Expert Recap: Orlando 2005 Report on Colorectal Cancer

Source: CCO Independent Conference Coverage of the 2005 Annual Meeting of the American Society of Clinical Oncology*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Expert Recap: Orlando 2005 Report on Colorectal Cancer

Program Director: Roy A. Beveridge, MD

Faculty:

John L. Marshall, MD

CME CREDIT INFORMATION

Release Date: 07/19/05

Expiration Date: 07/18/06

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss results evaluating first-line treatment strategies for metastatic colorectal cancer.
Describe data regarding the efficacy of treatment strategies in special populations with metastatic disease, including previously treated patients, irinotecan-refractory patients, and the elderly.
Recount data regarding the use of adjuvant therapy in colorectal cancer, including the efficacy of various agents in advanced disease.

CCO Expert Recap combining slides with audio commentary by John L. Marshall, MD.

Supported by an educational grant from Roche.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.